2252.HK Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 10:09):

Shanghai Microport Medbot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People's Republic of China and Europe...

Stats
Šios dienos apimtis	510 000
Vidutinė apimtis	1.14M
Rinkos kapitalizacija	14.03B
EPS	HKD0 ( 2024-03-29 )
Kita pelno data	( HKD0 ) 2024-06-20
Last Dividend	HKD0 ( N/A )
Next Dividend	HKD0 ( N/A )
P/E	-12.82
ATR14	HKD0.0280 (0.19%)

Tūris Koreliacija

Ilgas: -0.03 (neutral)

Trumpas: 0.96 (very strong)

Signal:(44.814) Expect same movement, but be aware

Shanghai MicroPort MedBot Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Shanghai MicroPort MedBot Koreliacija - Valiuta/Žaliavos

0.27
( neutral )

-0.03
( neutral )

0.00
( neutral )

-0.19
( neutral )

-0.42
( neutral )

-0.12
( neutral )

Shanghai MicroPort MedBot Finansinės ataskaitos

Annual	2023
Pajamos:	HKD104.59M
Bruto pelnas:	HKD14.69M (14.05 %)
EPS:	HKD-1.060

FY	2023
Pajamos:	HKD104.59M
Bruto pelnas:	HKD14.69M (14.05 %)
EPS:	HKD-1.060

FY	2022
Pajamos:	HKD21.60M
Bruto pelnas:	HKD6.56M (30.38 %)
EPS:	HKD-1.220

FY	2021
Pajamos:	HKD2.15M
Bruto pelnas:	HKD919 000 (42.74 %)
EPS:	HKD-0.612

Financial Reports:

No articles found.

Shanghai MicroPort MedBot

Shanghai Microport Medbot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People's Republic of China and Europe. It offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; Honghu, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot for coronary angioplasty; and iSR'obot, a Mona Lisa robotic transperineal prostate biopsy system. The company also provides spine surgical robots; trans-bronchial surgical robots for trans-bronchial diagnosis and treatment; TAVR surgical robots for heart valve replacement surgery; and automated needle targeting robotics systems for percutaneous lung biopsy and percutaneous nephrolithotomy. Shanghai Microport Medbot (Group) Co., Ltd. was founded in 2014 and is based in Shanghai, China. Shanghai Microport Medbot (Group) Co., Ltd. operates as a subsidiary of MicroPort Scientific Corporation.